Severe Inclusion Body Myositis with Interstitial Pneumonia

Shunsuke MORI; Hironobu HAMADA; Akihito YOKOYAMA; Nobuoki KOHNO; Keiichi KONDO; Yuji HARA; Hiroyuki KAWATA; Kunio HIWADA

doi:10.2169/internalmedicine.40.940

Shunsuke MORI, Hironobu HAMADA, Akihito YOKOYAMA, Nobuoki KOHNO, Keiichi KONDO, Yuji HARA, Hiroyuki KAWATA, Kunio HIWADA

Author information

Shunsuke MORI
the Second Department of Internal Medicine, Ehime University School of Medicine
Hironobu HAMADA
the Second Department of Internal Medicine, Ehime University School of Medicine
Akihito YOKOYAMA
the Second Department of Internal Medicine, Ehime University School of Medicine
Nobuoki KOHNO
the Second Department of Internal Medicine, Ehime University School of Medicine
Keiichi KONDO
the Second Department of Internal Medicine, Ehime University School of Medicine
Yuji HARA
the Second Department of Internal Medicine, Ehime University School of Medicine
Hiroyuki KAWATA
the Department of Internal Medicine, Kitaishikai Hospital
Kunio HIWADA
the Second Department of Internal Medicine, Ehime University School of Medicine

Keywords: inflammatory myositis, immunosuppressive agent, CD8

JOURNAL FREE ACCESS

2001 Volume 40 Issue 9 Pages 940-944

DOI https://doi.org/10.2169/internalmedicine.40.940

Details

Abstract

We report a patient with a severe inclusion body myositis (IBM). His illness was unusual in terms of a rapid progression, high creatine kinase levels, and complication with interstitial pneumonia. He responded well to immunosuppressive agents such as corticosteroids, cyclosporin A, cyclophosphamide, and immunoglobulin. The present patient indicates the wide range of the disease, and that immunosuppressive agents may be useful for treatment of IBM.
(Internal Medicine 40: 940-944, 2001)

Corresponding author

Register with J-STAGE for free!